ARCHIVES

A letter about FDA oncology consolidation reopens debate among cancer groups; FDA asks groups not to send letters, invites discussion.

This article is from The Cancer Letter archive.

Vol. 30 No. 23 | June 4, 2004

Download PDF Visit The Full Archive

Related Articles

RFAs In Bladder, Prostate, Ok’d By DCBDC Advisors

March 1, 1991

Four More Grants Planned By Prostatic Cancer Project This Year; Applications Still Accepted

August 30, 1974

$293 Million NCI Budget Cut To Drop Grant Success Rate

May 10, 2013

Elderly Patients Fail To Receive New Cancer Therapy For CML

August 27, 2010

Six-Year Follow Up Of Phase III Sprycel Trial Demonstrates 71 Percent Overall Survival

July 27, 2012

Slow Accruing Trials Should Be Removed From High Priority Program, Broder Says

October 2, 1992